Summary
Human enterovirus 71 has emerged as an important pathogen of children in the Asia Pacific region, and it may be important to consider the development of a vaccine against this virus. Human cord serum was used as a source of neutralizing antibodies to determine whether the N- or C-terminal half of the VP1 capsid protein was more likely to harbour neutralizing determinants. Cord sera from 205 individuals were tested for neutralizing antibodies against human enterovirus 71 in an indirect ELISA against recombinant VP1 antigen as well as the N- and C-terminal portions of VP1 antigen. High-titred human neutralizing antibodies were significantly more reactive with the N-terminal half of VP1 than weak or negative sera. The N-terminal half of human enterovirus 71 is likely to have important neutralizing antibody determinants and should be investigated further in vaccine development efforts.
Article PDF
Similar content being viewed by others
References
MJ Cardosa D Perera BA Brown D Cheon HM Chan KP Chan H Cho P McMinn (2003) ArticleTitleMolecular epidemiology of human enterovirus 71 strains and recent outbreaks in the Asia-Pacific region: comparative analysis of the VP1 and VP4 genes Emerg Infect Dis 9 461–468 Occurrence Handle12702227
MA Jimenez-Clavero E Escribano-Romero AJ Douglas V Ley (2001) ArticleTitleThe N-terminal region of the VP1 protein of swine vesicular disease virus contains a neutralization site that arises upon cell attachment and is involved in viral entry J Virol 75 1044–1047 Occurrence Handle11134318 Occurrence Handle10.1128/JVI.75.2.1044-1047.2001 Occurrence Handle1:CAS:528:DC%2BD3MXhsFahsw%3D%3D
T Kanno T Inoue Y Wang A Sarai S Yamaguchi (1995) ArticleTitleIdentification of the location of antigenic sites of swine vesicular disease virus with neutralization-resistant mutants J Gen Virol 76 IssueIDPt 12 3099–3106 Occurrence Handle8847515 Occurrence Handle1:CAS:528:DyaK2MXhtVSjtbrM Occurrence Handle10.1099/0022-1317-76-12-3099
P McMinn K Lindsay D Perera HM Chan KP Chan MJ Cardosa (2001) ArticleTitlePhylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia J Virol 75 7732–7738 Occurrence Handle11462047 Occurrence Handle10.1128/JVI.75.16.7732-7738.2001 Occurrence Handle1:CAS:528:DC%2BD3MXlsFKrs7s%3D
PC McMinn (2002) ArticleTitleAn overview of the evolution of enterovirus 71 and its clinical and public health significance FEMS Microbiol Rev 26 91–107 Occurrence Handle12007645 Occurrence Handle10.1111/j.1574-6976.2002.tb00601.x Occurrence Handle1:CAS:528:DC%2BD38Xjtl2itLw%3D
K Mizuta C Abiko T Murata Y Matsuzaki T Itagaki K Sanjoh M Sakamoto S Hongo S Murayama K Hayasaka (2005) ArticleTitleFrequent importation of enterovirus 71 from surrounding countries into the local community of Yamagata, Japan, between 1998 and 2003 J Clin Microbiol 43 6171–6175 Occurrence Handle16333123 Occurrence Handle10.1128/JCM.43.12.6171-6175.2005 Occurrence Handle1:CAS:528:DC%2BD28XktVShug%3D%3D
T Pulli M Roivainen T Hovi T Hyypia (1998) ArticleTitleInduction of neutralizing antibodies by synthetic peptides representing the C terminus of coxsackievirus A9 capsid protein VP1 J Gen Virol 79 IssueIDPt 9 2249–2253 Occurrence Handle9747735 Occurrence Handle1:CAS:528:DyaK1cXlvVWgtLs%3D
S van der Werf C Wychowski P Bruneau B Blondel R Crainic F Horodniceanu M Girard (1983) ArticleTitleLocalization of a poliovirus type 1 neutralization epitope in viral capsid polypeptide VP1 Proc Natl Acad Sci USA 80 5080–5084 Occurrence Handle6308670 Occurrence Handle10.1073/pnas.80.16.5080 Occurrence Handle1:CAS:528:DyaL3sXltlCks7g%3D
CN Wu YC Lin C Fann NS Liao SR Shih MS Ho (2001) ArticleTitleProtection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus Vaccine 20 895–904 Occurrence Handle11738755 Occurrence Handle10.1016/S0264-410X(01)00385-1 Occurrence Handle1:CAS:528:DC%2BD3MXptVSntbw%3D
CK Yu CC Chen CL Chen JR Wang CC Liu JJ Yan IJ Su (2000) ArticleTitleNeutralizing antibody provided protection against enterovirus type 71 lethal challenge in neonatal mice J Biomed Sci 7 523–528 Occurrence Handle11060501 Occurrence Handle10.1007/BF02253368 Occurrence Handle1:CAS:528:DC%2BD3cXos1yjur4%3D
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tan, CS., Cardosa, M. High-titred neutralizing antibodies to human enterovirus 71 preferentially bind to the N-terminal portion of the capsid protein VP1. Arch Virol 152, 1069–1073 (2007). https://doi.org/10.1007/s00705-007-0941-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00705-007-0941-1